Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Claude Dubois

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Clinical and Vaccine Immunology : CVI|September 24, 2010
Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adultsIsabel Leroux-Roels, Geert Leroux-Roels, Opokua Ofori-Anyinam, et al.
Human Vaccines|July 10, 2009
The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humansKenneth Von Eschen, Royce Morrison, Madeleine Braun, et al.
Plos One|November 17, 2010
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trialPedro Aide, John J Aponte, Montse Renom, et al.
Plos One|October 28, 2009
A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in GabonBertrand Lell, Selidji Agnandji, Isabelle von Glasenapp, et al.
Vaccine|May 6, 2008
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in miceJoseph P Shott, Shannon M McGrath, Maria Grazia Pau, et al.
Anaesthesia, Critical Care & Pain Medicine|February 27, 2019
Management of the child's airway under anaesthesia: The French guidelinesChristophe Dadure, Nada Sabourdin, Francis Veyckemans, et al.
Vaccine|December 11, 2007
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trialJahit Sacarlal, John J Aponte, Pedro Aide, et al.
Vaccine|March 30, 2011
Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trialPedro Aide, Carlota Dobaño, Jahit Sacarlal, et al.
Malaria Journal|January 10, 2013
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic regionSalim Abdulla, Nahya Salim, Francisca Machera, et al.
Lancet (London, England)|December 13, 2005
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical and Vaccine Immunology : CVI|September 24, 2010
Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adultsIsabel Leroux-Roels, Geert Leroux-Roels, Opokua Ofori-Anyinam, et al.
Human Vaccines|July 10, 2009
The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humansKenneth Von Eschen, Royce Morrison, Madeleine Braun, et al.
Plos One|November 17, 2010
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trialPedro Aide, John J Aponte, Montse Renom, et al.
Plos One|October 28, 2009
A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in GabonBertrand Lell, Selidji Agnandji, Isabelle von Glasenapp, et al.
Vaccine|May 6, 2008
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in miceJoseph P Shott, Shannon M McGrath, Maria Grazia Pau, et al.
Anaesthesia, Critical Care & Pain Medicine|February 27, 2019
Management of the child's airway under anaesthesia: The French guidelinesChristophe Dadure, Nada Sabourdin, Francis Veyckemans, et al.
Vaccine|December 11, 2007
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trialJahit Sacarlal, John J Aponte, Pedro Aide, et al.
Vaccine|March 30, 2011
Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trialPedro Aide, Carlota Dobaño, Jahit Sacarlal, et al.
Malaria Journal|January 10, 2013
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic regionSalim Abdulla, Nahya Salim, Francisca Machera, et al.
Lancet (London, England)|December 13, 2005
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
Pageof 4